ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,874.40
      -0.06%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Kintara Therapeutics Inc (KTRA)

      7. Kintara Therapeutics Inc (KTRA) Financials

      Kintara Therapeutics Inc

      Kintara Therapeutics Inc (KTRA)

      NASDAQ
      0.2448
      0.0276
      (12.71%)
      Closed July 26 4:00PM
      Delayed by 15 minutes
      0.2477
      0.0029
      (1.18%)
      After Hours: 7:50PM
      Delayed by 15 minutes

      Kintara Therapeutics Inc Financial Summary

      The current KTRA market cap is 13.7M. The company's latest EPS is USD -0.2716 and P/E is -0.88.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -3.3M-3.35M-2.96M-1.02M-2.09M
      Net Income -3.63M-3.34M-3.14M-1.03M-2.01M
      Year End June 29 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -8.4M-9.2M-38.17M-22.68M-14.8M
      Net Income -8.13M-9.14M-41.5M-22.66M-15.02M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 6.74M3.98M1.48M1.89M7.45M
      Total Liabilities 2.95M3.25M3.5M2.05M1.52M
      Total Equity 3.79M731k-2.03M-164k5.92M
      Year End June 29 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 4.04M2.94M13.54M15.95M3.98M
      Total Liabilities 2.07M2.68M2.96M4.15M3.25M
      Total Equity 1.97M263k10.58M11.8M731k

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -10.36M-11.87M-1.32M-3.43M-5.73M
      Investing -232k-232k N/A -20k-20k
      Financing 1.85M1.85M-2k2.58M10.57M
      Year End June 29 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -6.33M-7.93M-18.86M-20.39M-11.87M
      Investing N/A N/A 964k N/A -232k
      Financing 4.07M6.6M26.04M21.64M1.85M

      Stats and Ratios

      Market Cap 13.7M
      Price to Earnings Ratio -0.88
      Price to Sales Ratio 0
      Price to Cash Ratio 8.63
      Price to Book Ratio 18.16
      Dividend Yield -

      Share Statistics

      Shares Outstanding 55.3M
      Average Volume (1 week) 2.59M
      Average Volume (1 Month) 4.22M
      52 Week Change -94.63%
      52 Week High 5.00
      52 Week Low 0.081
      Spread (Intraday) 0.01 (3.11%)

      Company Info

      Company Name Kintara Therapeutics Inc
      Address 50 west liberty street
      reno, nevada 89501
      Website https://www.kintara.com
      Industry pharmaceutical preparations (2834)